COVID Infection Provides Immunity Equal to Vaccination: Study

COVID Infection Provides Immunity Equal to Vaccination: Study

Feb. 17, 2023 — The natural immunity provided by a COVID infection protects a person against severe illness on a par with two doses of mRNA vaccine, a new study says.

But protection against the BA.1 subvariant of Omicron was not as high – 36% at 10 months after infection, says the research team from the Institute for Health Metrics and Evaluation at the University of Washington.

The researchers examined 65 studies from 19 countries through Sept. 31, 2022. They did not study data about infection from Omicron XBB and its sub-lineages. People who had immunity from both infection and vaccination, known as hybrid immunity, were not studied.

Scientists Find a New Coronavirus in Bats That Is Resistant to Current Vaccines

Scientists Find a New Coronavirus in Bats That Is Resistant to Current Vaccines

The findings come as the World Health Organization’s (WHO) ACT—Accelerator’s Council Tracking and Accelerating Progress—working group report that continued response to the COVID-19 pandemic, in the form of testing, vaccinations, and treatments, is stalling. With lower global immunity to the current SARS-CoV-2 virus, combating any new pathogens, including new coronaviruses like Khosta-2, would become more difficult. According to the latest data collected by the WHO, a quarter of people around the world still have not received a primary series of COVID-19 vaccination.

They just won’t give up! It’s over!

BUT WHY?! Kenya Has Zero Cases But U.S Pharmaceutical Firm To Start Vaccine Trial + WHO Issues Monkeypox Advisory to Kenya

Video via Wongel Zelalem

Tonix will test its monkeypox vaccine in Kenya next year, and no eyes on accelerated path at FDA

The study of Tonix Pharmaceuticals’ live virus vaccine will occur at Kenya Medical Research Institute, or KEMRI, in the East African country, the partners said Thursday. While Kenya has no reported cases of the virus that leads to painful lesions, the country is close to the Democratic Republic of the Congo, which had 163 cases as of July 27, according to a CDC tracker.

Tonix has been working on monkeypox and smallpox for close to a decade, Lederman said. The company’s vaccine, dubbed TNX-801, is traced back to a research collaboration with the Department of Cell Biology at the University of Alberta.

Related:

Read More »

Biden tests positive for COVID-19, has ‘very mild symptoms’

By ZEKE MILLER and CHRIS MEGERIAN, Associated Press

WASHINGTON (AP) — President Joe Biden tested positive for COVID-19 on Thursday and is experiencing “very mild symptoms,” the White House said, as new variants of the highly contagious virus are challenging the nation’s efforts to get back to normal after two and a half years of pandemic disruptions.

Biden tests positive for COVID-19, has ‘very mild symptoms’